ZimVie Inc. reported second quarter 2025 net sales of $116.7 million on July 30, 2025, a decrease of 0.1% on a reported basis and 2.1% in constant currency compared to the second quarter of 2024. The net loss for the quarter improved by $5.7 million to $(3.8) million, with an adjusted diluted EPS of $0.26.
Adjusted EBITDA for the second quarter was $17.5 million, representing a 15.0% margin, an increase of 150 basis points year-over-year. These results reflect the company's continued focus on operational execution and efficiency.
Due to the pending acquisition by an affiliate of ARCHIMED, ZimVie confirmed that it would not host a conference call for the second quarter and officially withdrew its fiscal 2025 guidance. This decision aligns with the company's transition to becoming a privately held entity upon the transaction's expected close by year-end 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.